Vincristine, Dactinomycin, and Cyclophosphamide in Treating Patients With Embryonal Rhabdomyosarcoma
Clinical trial NCT00245089 · UNKNOWN
Trial details
- NCT number
- NCT00245089
- Sponsor
- Japan Rhabdomyosarcoma Study Group
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-05-01
- Primary completion
- 2011-04-01
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.